because it spells out CBIS recent dealings in detail... You have to look at the exhibits, not just the filings. They are finally outlining a real business plan with their new executives and the deals are now fully disclosed so no more guesswork.
Now we see if the plan comes to fruition or if it was worth it at all imo.
IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above.
CANNABIS SCIENCE, INC.
Per: /s/ Robert Melamede ___________________________ Dr. Robert Melamede, President
Consultant’s duties include, but are not limited to the following:
Director of Horticulture:
Develop and Maintain Growing Standards (processed and procedures) for, including but not limited to: i. the maintaining of healthy mother plants dedicated to cloning and guaranteed to be females. ii. Cloning, vegetative growth, CBIS extractions, formulations, and analytics. iii. Utilizing any material from harvest, including stalks and leaves, for use in downstream extracts and formulations. iv. Growth and maintenance of (proprietary) CBIS transgenic strains generated by the lab division. v. Growth and maintenance of micropropagated clones generated by the lab division. vi. Any other responsibilities seen to be properly designated by CBIS in the production of high grade medical marijuana. vii. Including, but not limited to lights, hydroponic trays and growth pots, water pumps, airflow devices (intake/exhaust), carbon filters, growth media, nutrients, antimicrobials, and any other equipment necessary for the production of hydroponically or soil-grown medical marijuana.
Development of Plants/Strains: i. Procuring and development of plants and strains for optimal CBIS medical marijuana production.
c. Grow Operations: i. Design and management of Research and Development facilities. ii. Setup of equipment. iii. Manage facility production.
d. Training and Management: i. Train and oversee various operations staff.
Laboratory/MIPS Facilities/Product Development: i. Assist with set up of laboratory and product development team member ii. Assist with laboratory relationships
Manufacture Facilities: i. Assist with set up of manufacture ii. Assist with manufacture relationships
IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above.
CANNABIS SCIENCE, INC.
Per: /s/ Robert Melamede ___________________________ Dr. Robert Melamede, President
CONSULTANT:
Per: /s/ Mohammed Afaneh _______________________________ Dr. Mohammad Afaneh
APPENDIX “A”
Consultant’s duties include, but are not limited to the following:
Chief Operating Officer:
Develop and Maintain Operational Growth Standards (processed and procedures) for, including but not limited to: i. the maintaining of daily operations within the organization. Maintaining of the day to day of the various departments within the organization. ii. Manage the product development for medical patients for critical ailments and for use in downstream CBIS extractions, formulations, and analytics.
Areas Of Responsibility:
THE MARKET OPPORTUNITIES FOR WHOLE PLANT PHARMACEUTICALS 1. Markets of Interest a) FDA Track Drug Approval - Nationwide i. PTSD & Chronic Pain ii. Additional Indications of Interest b) States with Approved Medical Marijuana Grow Plans 2. Our Future Product Line: Various Medical Cannabis Preparations a) Pharmaceuticals - Oral & Topical Containing: i. Phytocannabinoids ii. Synthetic Cannabinoids iii. Hybrids b) Nutraceuticals - Psychologically Inactive i. Dietary Supplements, i.e. Hemp-Based Foods ii. Topical Lotions, Salves, Balms, Creams
Whole Plant Pharmaceutical Products: i. Psychoactive Medicines (Drugs) ii. Non-psychoactive Neutroceuticals iii. Botanical Medicines iv. Research & Development v. Formal testing/ Licensing (FDA, State or Federal jurisdictions) vi. Commercial Licensing vii. Commercialization (Manufacturing/Production) viii. Multiple-Market (Countries) Penetration
Delivery Methods: i. Lozenge ii. Strips iii. Cream iv. Liquid v. Pills vi. Extracts
PRIORITIES/MILESTONES i. Grand Opening of Cannabis Science Executive Offices, as well as cGMP compliant Lab Division, and Production Division, and Extraction Division. ii. Continued collaboration with our Advisory Boards and Consultation Firms with respect to meeting the highest quality standards in the nation. iii. Utilizing our quality products in local Colorado randomized, placebo-controlled trials in PTSD and Chronic Pain cohort groups. iv. Continued investigation and collaboration with several partners in our investigation into the proper route and product for IND application to the FDA, including the possibility of accelerated approval. v. Further consultations and investigations into US Military and Government contracts to provide cannabis-based medications for our veterans and soldiers.
INITIAL TARGET MARKET United States (USA) i. FDA Clinical Human Trials: Cancer, PTSD, Influenza ii. US Military: PTSD, Chronic Pain iii. Asthma iv. Arthritis
Development of Plants/Strains: i. Procuring and development of plants and strains for optimal CBIS medical marijuana production.
d. Grow Operations: i. Design and management of marijuana grow facilities. ii. Setup of growing equipment. iii. Manage plant production.
e. Training and Management: i. Train and oversee various operations staff.
Laboratory Facilities/Product Development: i. Assist with set up of laboratory and product development team member ii. Assist with laboratory relationships
Manufacture Facilities: i. Assist with set up of manufacture ii. Assist with manufacture relationships
Dispensary/Clinical Facilities: i. Manage set up of dispensary and clinical facilities ii. Manage dispensary and clinical relationships
Marketing/Distribution: i. Manage set up of marketing and distribution ii. Manage marketing and distribution relationships GGECO University: i. Manage operations ii. Develop marketing protocols Television Show Development: i. Concept development ii. Distribution agreements